Low-intensity combination chemotherapy maximizes host survival time for tumors containing drug-resistant cells
DOI10.1016/0025-5564(92)90039-YzbMath0764.92012OpenAlexW2037548799WikidataQ52418650 ScholiaQ52418650MaRDI QIDQ1196633
R. F. Minchin, Michael E. Fisher, R. Bruce Martin, Kok Lay Teo
Publication date: 16 January 1993
Published in: Mathematical Biosciences (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/0025-5564(92)90039-y
nonlinear optimizationsimulationsclinical trialscancer chemotherapydrug concentrationdrug toxicitycombinations of drugsdose intensitydrug-resistant cellsexponential and logistic tumor growth modelsfixed terminal time problemsGompertz tumor growthhost survival time
Differential games and control (49N70) Medical applications (general) (92C50) Pursuit and evasion games (49N75)
Related Items (9)
Uses Software
Cites Work
- A computational algorithm for functional inequality constrained optimization problems
- A model for the resistance of tumor cells to cancer chemotherapeutic agents
- The effect of cellular differentiation on the development of permanent drug resistance
- Control parametrization: a unified approach to optimal control problems with general constraints
- Models for dose intensity
- A stochastic model for the origin and treatment of tumors containing drug-resistant cells
- A mathematical model of cancer chemotherapy with an optimal selection of parameters
- Alternative algorithms for solving nonlinear function and functional inequalities
This page was built for publication: Low-intensity combination chemotherapy maximizes host survival time for tumors containing drug-resistant cells